ESC 365 - Aminoterminal proB-type natriuretic peptide: a key parameter to optimise therapeutic management of low-flow, low-gradient aortic stenosis

ESC Premium Access

Aminoterminal proB-type natriuretic peptide: a key parameter to optimise therapeutic management of low-flow, low-gradient aortic stenosis

Session: Understanding and treating low gradient aortic stenosis

Topic: Intervention

Speaker: Doctor M. Annabi (Quebec, CA)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Mohamed Salah Annabi

Quebec Heart and Lung Institute, Quebec (Canada)

1 presentation

0 follower

3 more presentations in this session

State of the Art in low gradient aortic stenosis diagnosis and management

Speaker: Professor J. Vanoverschelde (Brussels, BE)

The role of diastolic function in risk stratification of patients with moderate aortic stenosis

Speaker: Doctor S. Ito (Rochester, US)

Impact of aortic valve replacement on outcomes of patients with low-flow, low-gradient moderate aortic stenosis

Speaker: Doctor M. Annabi (Quebec, CA)

Access the full session

Understanding and treating low gradient aortic stenosis

Speakers: Doctor M. Annabi, Professor J. Vanoverschelde, Doctor S. Ito, Doctor M. Annabi

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources